Therapeutic Strategies in the Cognitive Impairment of Schizophrenia.

We will first have an historical survey of cognitive impairment in schizophrenia, with special reference to Emil Kraepelin and Eugen Bleuler. We will then consider the types of cognitive schizophrenia-wise deficits, the assessment of cognitive impairment, the clinical significance of cognitive impairment, the neurocognitive predictors of functionality, psychopharmacology and cognitive function. We will finally state that partial compliance is the main cause of high dropout rates. [ABSTRACT FROM AUTHOR]